Prof. Dr. Marcelo Merello

1. Dystonia and reflex sympathetic dystrophy induced by ergotamine. MERELLO MJ, Nogues MA, Leiguarda RC, Lopez Saubidet C. Mov Disord 1991; 6 (3): 263-264. 2. Subarachnoid and intramedullary cysts secondary to epidural anesthesia for gynecological surgery. Nogues MA, MERELLO MJ, Leiguarda RC, Guevara J, Figari A. Eur Neurol 1992; 32 (2): 99-101 3. Impaired levodopa response in Parkinson´s disease during melanoma therapy. MERELLO MJ, Esteguy M, Perazzo F, Leiguarda RC. Clin Neuropharmacol 1992; 15 (1): 69-74. 4. Convulsiones inducidas por OKT3 [Seizures induced by OKT3]. MERELLO MJ, Nogues MA, Leiguarda RC, Davalos M, Jost L. Medicina 1991, 51: 581. 5. SEPs and CNS magnetic stimulation in syringomyelia. Nogues MA, Pardal AM, MERELLO MJ, Miguel MA. Muscle Nerve 1992; 15 (9): 993-1001. 6. Beginning-of-dose motor deterioration following the acute administration of levodopa and apomorphine in Parkinson's disease. MERELLO MJ, Lees AJ. J Neurol Neurosurg Psychiatry 1992; 55 (11): 1024-1026. 7. Cardiovascular reflexes in Parkinson´s disease: Effect of domperidone and apomorphine. MERELLO MJ, Pirtosek Z, Bishop S, Lees AJ. Clin Auton Res 1992; 2 (4): 215-219. 8. Abnormal sympathetic skin response in patients with autoimmune vitiligo and primary autoimmune hypothyroidism. MERELLO MJ, Nogues MA, Leiguarda RC, Lopez Saubidet C, Florin A. J Neurol 1993; 240 (2): 72-74. 9. Preclamol and Parkinsonian Fluctuations. Pirtosek Z, MERELLO MJ, Carlsson A, Stern GM. Clin Neuropharmacol 1993; 16: 550-554. 10. Aracnoiditis espinal como complicacion de anestesia peridural [Spinal arachnoiditis as a complication of peridural anesthesia]. Torres D, Bauso-Tossili L, Vecchi E, Leiguarda RC, Doctorovich D, MERELLO MJ, Guevara J, Nogues MA. Medicina (B Aires) 1993; 53 (5): 391-396. 11. Inverse masticatory muscle activity due to syringobulbia. MERELLO MJ, Lees AJ, Leiguarda RC, Guevara J, Nogues MA. Mov Disord 1993; 8 (3): 359-360. 12. Effect of entacapone, a peripherally acting catechol-O-methyltransferase inhibitor, on the motor response to acute treatment with levodopa in patients with Parkinson's disease. MERELLO MJ, Lees AJ, Webster R, Bovigdon M, Gordin A. J Neurol Neurosurg Psychiatry 1994; 57 (2): 186-189. 13. The nature of apraxia in corticobasal degeneration. Leiguarda RC, Lees AJ, MERELLO MJ, Starkstein S, Marsden CD. J Neurol Neurosurg Psychiatry 1994; 57 (4): 455-459. 14. Bromocriptine-induced dystonia in patients with aphasia and hemiparesis. Leiguarda RC, MERELLO MJ, Sabe L, Starkstein S. Neurology 1993; 43 (11): 2319-2322. 15. Masticatory muscle spasm in a non-Japanese patient with Satoyoshi syndrome successfully treated with botulinum toxin. MERELLO MJ, Garcia H, Nogues MA, Leiguarda RC. Mov Disord 1994; 9 (1): 104-105. 16. Extrapyramidal signs in Alzheimer disease prevalence psychiatric and neurophysiologic correlates. MERELLO MJ, Sabe L, Teson A, Migliorelli R, Petracchi M, Leiguarda RC, Starkstein S. J Neurology Neurosurgery Psychiatry 1994; 57:1503-1509. 17. Adynamic bowel syndrome with dramatic response to apomorphine. MERELLO MJ, Leiguarda RC. Clin Neuropharmacol 1994; 17: 574-578. 18. A SPECT study of Parkinsonism in Alzheimer's Disease. Starkstein S. Vazquez S, MERELLO MJ, Tesón A, Petracchi M, R Leiguarda. J Neuropsychiatry 1995;7:308-313. 19. Tratamiento de la enfermedad de Parkinson con apomorfina.[Treatment of Parkinson's disease with apomorphine]. MERELLO MJ, Leiguarda RC. Medicina 1995; 55: 5-10. 20. Clinical usefulness of apomorphine in movement disorders. Colosimo C, MERELLO MJ, Albanese A. Clin Neuropharmacol 1994; 17 (3): 243-259. 21. Catatonia in depression: prevalence, clinical correlates, and validation of a scale. Starkstein S, Petracca G, Teson A, Chemerinski E, MERELLO M, Migliorelli R, Leiguarda R. Neurology, Neurosurgery and Psychiatry 60: 326-332, 1996. 22. Drug induced parkinsonism in schizophrenic patients: motor response and psychiatric changes after acute challenge with L-dopa and apomorphine. MERELLO M, Starkstein S, Petracca G, Amado Cataneo E, Manes F, Leiguarda R. Clinical Neuropharmacology 1996: 19 (5): 439-443. 23. The motor response to acute dopaminergic challenge with apomorphine and l-dopa in Parkinson’s disease. Implications for the pathogenesis of the on-off phenomenon. Colosimo C, MERELLO M, Hughes AJ, Sieradzan K, Lees AJ. J Neurology Neurosurgery Psychiatry 1996; 61: 634-637. 24. Amantadine in parkinsonian patients unresponsive to levodopa: a pilot study. Colosimo C, MERELLO M, Pontieri F. J Neurology 1996; 243:422-425. 25. Comparison of subcutaneous Apomorphine versus dispersable Madopar latency and effect duration in Parkinson’s disease patients: A double-blind single-dose study. MERELLO M, Pikielny R, Cammarota A, Leiguarda R. Clinical Neuropharmacol 1997; 20 (2): 165-167. 26. The nature of apraxia In Parkinson's disease and neuroleptic-induced Parkinsonism. Leiguarda R, Pramstaller P, MERELLO M, Starkstein S, Sabe L, Less AJ, Marsden CD. Brain 1997; 120: 75-90. 27. Sleep benefit in Parkinson's disease. MERELLO M, Hughes A, Hoffman M, Colosimo C, Starkstein S, Leiguarda R. Mov. Disorders 1997; 12:506-508. 28. Involuntary movements during thermolesion predict a better outcome after microelectrode-guided postero-ventral pallidotomy. MERELLO M, Cammarota A, Betti O, Nouzeilles M, Cerquetti D, Garcia H, Pikielny R, Leiguarda R. J Neurology Neurosurgery Psychiatry 1997; 67:210-213. 29. Palidotomia posteroventral bajo control electrofisiológico como tratamiento de la enfermedad de Parkinson. MERELLO M, Cammarota A, Betti O, Garcia H, Cerquetti D, Pikielny R, Leiguarda R Archivos de Neurología, Neurocirugía y Neuropsiquiatría 1997; 1: 32-40 30. Correlation between results of motor section of UPDRS and Webster scale. Nouzeilles MI, MERELLO M. Movement Disorders 1997;12:613. 31. Changes in motor response to acute l-dopa challenge after unilateral microelectrode guided postero-ventral pallidotomy. MERELLO M, Nouzeilles MI, Cammarota A, Pikielny R, Leiguarda R. Clinical Neuropharmacology 1998; 21(2):135-138. 32. Confirmation of the anti-dyskinetic effect of microelectrode-guided postero-ventral pallidotomy by means of intra-surgical apomorphine test. MERELLO M, Cammarota A, Nouzeilles MI, Betti O, Leiguarda R Movement Disorders 1998;13/3: 533-535. 33. Movement quality of repetitive self-paced single joint rapid arm movements on Parkinson’s disease: acute effect of l-dopa. MERELLO M, Balej J, Starkstein S, Leiguarda R. Parkinsonism and Related Disorders 1998; 4: 31-37 34. SPECT study of parkinsonism in Alzheimer’s disease. Starkstein S, Vazquez S, MERELLO M, Teson A, Petracchi M, Leiguarda R. Neuropsychiatry and Clinical Neurosciences 1995; 7: 308-131,. 35. Neuropsychological and psychiatry differences between Alzheimer’s disease and Parkinson’s disease with dementia. Starkstein S, Sabe L, Petracca G, Chemerinski E, Kuzis G, MERELLO M, Leiguarda R. Journal of Neurology, Neurosurgery and Psychiatry 1996; 61: 381-387. 36. Spect findings in Alzheimer’s disease and Parkinson’s disease with dementia. Starkstein S, Vazquez S, Petracca G, Sabe L, MERELLO M, Leiguarda R European Journal of Neurology 1997; 4 (3):231-136. 37. Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism. Leiguarda R, Pramstaller P., MERELLO M., Starkstein S., Lees AJ., Marsden D. Brain 1997; 120:75-90. 38.Depression in Classic Versus Akinetic-Rigid Parkinson's Disease. Starkstein S., Petracca G., Chemerinski E, Tesón A., Sabe L., MERELLO M., Leiguarda R. Mov Disord 1998; 13 (1): 29-33. 39.Apomorphine responses in Parkinson’s disease and the pathogenesis of motor complications. Colosimo C, MERELLO M, Hughes AJ, Sieradzan K, Lees AJ. Neurology 1998; 50 (2): 573-4. 40.Apomorphine induces changes in GPI spontaneous outflow in patient with parkinson's disease. MERELLO M, Balej J, Delfino M, Cammarota A, Betti O, Leiguarda R. Mov Disord 1999; 14/1: 45-49. 41.Unilateral radiofrequency lesion versus electrostimulation of posteroventral pallidum: a prospective randomized comparison. MERELLO M, Nouzeilles MI, Kuzis G, Cammarota A, Sabe L, Betti O, Starkstein S, Leiguarda R. Mov Disord 1999; 14/1: 50-56. 42.Comparison of 1-year follow-up evaluations of patients with indication for pallidotomy who did not undergo surgery versus patients with parkinson’s disease who did undergo pallidotomy: a case control study. MERELLO M, Nouzeilles MI, Cammarota A, Betti O, Leiguarda R Neurosurgery 1999; 44/3: 1-7. 43.GPI firing rate modification during beginning-of-dose motor deterioration following acute administration of apomorphine. MERELLO M, Lees A, Balej J, Cammarota A, Leiguarda R. Mov Disord 1999; 14 (3): 481-483. 44.Effect of Memantine (NMDA antagonist) on Parkinson’s disease: A double blind crossover randomized study. MERELLO M., Nouzeilles MI., Lees A., Balej J., Cammarota A., Leiguarda R. Clinical Neuropharmacol 1999; 22 (5): 273-276. 45.Prospective evaluation of Parkinsonism and tremor in patients treated with Valproate. Nouzeilles MI., Garcia H., Rabinowicz A., MERELLO M., Leiguarda R. Parkinsonism and Related Disorders 1999; 5: 67-68. 46.Subthalamic stimulation contralateral to a previous pallidotomy: An erroneous indication? MERELLO M. Movement Disorders 1999; 14 (5): 890. 47.Explicit and implicit learning in patients with Alzheimer disease and Parkinson disease with dementia. Kuzis G., Sabe L., Tiberti C., MERELLO M., Starkstein SE. Neuropsychiatry Neuropsychol Behav Neurol. 1999, 12(4):265-9. 48.Anatomia funcional de los ganglios basales. MERELLO M. Archivos de Neurología, Neurocirugía y Neuropsiquiatría 1999; Vol. 3 (1): 11-18. 49.Tratamiento quirúrgico de la enfermedad de Parkinson. MERELLO M. Archivos de Neurología, Neurocirugía y Neuropsiquiatría 2000; Vol. 4 N°1: 11-22. 50.Disruption of spatial organization and interjoint coordination in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. Leiguarda R, MERELLO M, Balej J, Starkstein S, Nogués M. Mov Disord, 2000; 15 (4): 627-640. 51.Functional anatomy of the basal ganglia. MERELLO M, Cammarota A. Rev Neurol. 2000 Jun 1-15;30(11):1055-60. 52.Mismatch between electrophysiologically defined and ventriculography based theoretical targets for posteroventral pallidotomy in Parkinson’s disease. MERELLO M, Cammarota A, Cerquetti D, Leiguarda R. J Neurol Neurosurg Psychiatry 2000 (6): 787-791. 53.Bilateral subthalamic nucleus stimulation in a parkinsonian patient with prevoius unilateral pallidotomy and thalamotomy. MERELLO M Reply. Mov Disord 2000 15 (4): 753-754. 54.Bilateral pallidotomy for treatment of Parkinson’s disease induced corticobulbar syndrome and psychic akinesia avoidable by globus pallidus lesion combined with contralateral stimulation. MERELLO M, Starkstein S, Nouzeilles MI, Kuzis G, Leiguarda R. J Neurol Neurosurg Psychiatry 2001 71(5): 611-614. 55.Movement quality of repetitive self-spaced single joint rapid arm movements on Parkinson’s disease patients acute effect of L-dopa. MERELLO M., Balej J., Starkstein S., Leiguarda R. Parkinsonism and Related Disorders, 2001. 56.Prevalence and correlates of Parkinsonism in patients with primary depression. Starkstein S., Petracca G., Chemerinski E, MERELLO M. Neurology 2001; 57:553-555. 57.Neuropsychological effects of pallidotomy in patients with Parkinson’s disease. Kuzis G, Sabe L, Tiberti C, MERELLO M, Pikielny R, Starkstein S Journal of Neurology, Neurosurgery and Psychiatry, 2001; 71:563-564. 58.Accuracy of acute l-dopa challenge for clinical prediction of sustained long-term l-dopa response as a major criterion for idiopathic Parkinson’s disease diagnosis. MERELLO M, Nouzeilles MI, Piran Arce G, Leiguarda R. Mov Disord 2002; 17 (4): 795-798. 59.Bilateral lesions restricted to the posteroventral pallidum are unlikely to provoke corticobulbar syndrome and psychic akinesia. Author’s reply. MERELLO M. J Neural Neurosurg Psychiatry 2002; 73:96-102. 60.Pallidotomy in Parkinson's disease improves single-joint, repetitive, ballistic movements, but fails to modify multijoint, repetitive, gestural movements. MERELLO M, Balej J, Leiguarda R. Mov Disord 2003 Mar; 18(3), 280-6 61.Neuronal globus pallidus activity in patients with generalised dystonia. MERELLO M, , Cerquetti D, Cammarota A, Tenca E, Artes C, Antico J, Leiguarda R. Mov Disord 2004; vol 19; 548-554. 62.Functional surgery of Parkinson's disease treatment: structured analisys of a decade of published literature. Boucai L, Cerquetti D, MERELLO M. Br J Neurosurg 2004; vol 18 (3), 213-22. 63.Actividad neuronal del globo pálido en pacientes con distonía generalizada. MERELLO M, Cerquetti D, Cammarota, Tenca E, Artes C, Antico J, Leiguarda R Archivos de Neurología, Neurocirugía y Neuropsiquiatría 2004; 9: 12-21 64.Rasagiline as an adjunct to levodopa in patients with Parkinson’s Disease and motor fluctuations (LARGO, lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial. Rascol O, Brooks, DJ, Melamed E, Oertel W, Poewe W, Stocchi, F, Tolosa E. for the largo study group. Lancet 2005; vol. 365, 947-954. 65.Bilateral Mirror Writing Movements (Mirror Dystonia) in a Patient With Writer’s Cramp: Functional Correlates. MERELLO M, Carpintiero S, Cammarota A, Meli F, Leiguarda R. Mov. Disord 2005, 21(5): 683-689. 66.Dyskinesias induced by subthalamotomy in Parkinson`s disease are unresponsive to Amantadine. MERELLO M, Perez Loret S, Antico J, Obeso J. J Neurol Neurosurg Psychiatry 2006;77;172-174 doi. 10.1136/jnnp.2005.068940 67.Neuronal activity of the zona incerta in Parkinson`s disease patients. MERELLO M, Tenca E, Cerquetti D. Movement Disord 2006 Jul;21(7):937-43. 68.Julio Cortazar Quotes on normal and abnormal movements magic realism o reality. MERELLO M,. Mov.Disord 2006 Aug; 21(8):1062-5. 69.The Parkinson-Control study, a 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with L-Dopa in Parkinson`s disease. Castro-Caldas A, Delwaide P, Jost W, MERELLO M, Williams A, Lamberti P, Aguilar M, Del Signore S, Cesaro P; Parkinson-Control Study Group. Movement Disorders 2006 Apr; 21 (4): 500-9. 70.Validation of a new scale for the evaluation of sialorrhea in Patients with Parkinson`s Disease. Santiago Perez Lloret, Gabriel Pirán Arce, Malco Rossi, María Laura Caivano Nemet, Paz Salsamendi, Marcelo MERELLO. Movement Disorders 2007.Jan;22(1):107-11. 71.The Unified Parkinson’s Disease Rating Scale: Validation Study of the Mentation, Behavior and Mood Section. Starkstein, Sergio, MD, PhD and MERELLO, Marcelo, MD, PhD. Movement Disorders Vol. 00 No. 0 2007 72.A Validation Study of Depressive Syndromes in Parkinson’s Disease. Starkstein SE, MERELLO M, Jorge R, Brockman S, Bruce D, Petracca G, Robinson RG. Mov Disord. 2008 Mar 15;23(4):538-46 73.Validation of the sleep related items of the Non-motor Symptoms Questionnaire for Parkinson’s disease (NMSQuest)”. Merelo, Marcelo, MD, PhD; Pérez Lloret, Santiago, MD; Rossi, Malco, MD; Cardinalli, Daniel, MD, PhD. Parkinsonism and Related Disorders 14(2008) 641-645. 74.The Athlete With Muscular Cramps: Clinical Approach. MERELLO, Marcelo, MD, PhD; Maquirriain, javier, MD, PhD: Journal of the American Academy of Orthopaedic Surgeons, Dec. 2007 75.Ictal non-forced grasping behaviour. Leiguarda RC, MD; Nouzeilles I, MD; Ugarnes G, MD; Amengual A, MD; Roldán E, MD; Fridman E, MD; D’Giano C, MD and MERELLO MJ, MD. Eur J Neurol. 2008 Feb; 15(2):169-172. 76.Phenomenology of abnormal movements in stuttering. Riva-Posse P, Busto-Marolt L, Schteinschnaider A, Martinez-Echenique L, Cammarota A, MERELLO M. Parkinsonism Relat Disord. 2008;14(5):415-9. Epub 2008 Mar 7. 77.Prospective randomized one year follow up comparison of bilateral subthalamotomy versus bilateral subthalamic stimulation and the combination of both in Parkinson's disease patients: a pilot study. MERELLO M, Tenca E, Lloret SP, Martin ME, Bruno V, Cavanagh S, Antico J, Cerquetti D, Leiguarda R. Br J Neurosurg. 2008 Jun; 22(3):415-22 78.Kinematic evaluation of gestural and repetitive single joint movements of the arm after posteroventral pallidotomy, subthalamotomy or both procedures combined in two Parkinson's disease patients: two case studies. MERELLO M, Balej J, Tenca E, Leiguarda R. Eur J Neurol. 2008 Apr;15(4):406-12. 79.Sialorrhoea and Drooling in Patients with Parkinson’s disease: Epidemiology and Management. MERELLO. M. Drugs Aging 2008;25(12):1007-19 80.Apathy predicts more severe parkinsonism in Alzheimer’s disease. Starkstein, Sergio, MD, PhD; MERELLO, Marcelo, MD, PhD; Brockman, Simone, MA; Bruce, David, MD; Petracca, Gustavo, MD; Power, Brian D., MD, PhD Am J Geriatr Psychiatry. 2009 Apr;17(4):291-8 81.Non- motor disorders in Parkinson’s disease. MERELLO, M. J. Neurol. 2008 Sep; 47(5):261-70. 82.Addenbrooke’s cognitive examination (ACE) validation in Parkinson’s disease. Reyes MA, Perez Lloret S, Roldan Gerscovich E, Martin ME, Leiguarda R, MERELLO M. Eur J Neurol. 2009 Jan;16(1):142-7. 83.Perez Lloret S, Amaya M, MERELLO M. Pregabalin-induced parkinsonism: a case report. Clin Neuropharmacol. 2009 Nov-Dec;32(6):353-4. doi: 10.1097/WNF.0b013e3181a9eb1b. PubMed PMID: 19952879. 84.Actigraphic evaluation of motor fluctuations in Parkinson’s Disease patients. Perez-Lloret S, Rossi M, Cardinali D, MERELLO M. International Journal of Neurosciences, 119:1-14, 2009. 85.Validation of the sleep related items of the Non-motor Symptoms Questionnaire for Parkinsons’s disease (NMS Quest). MERELLO M, Perez Lloret S, Rossi M, Cardinali DP. Parkinsonism Relat Disord. 2008 Dec;14(8):641-5. 86.Globus pallidus internus firing rate modification after motor-imagination in three Parkinson’s disease patientes. Leiguarda R, Cerquetti D, Tenca E, MERELLO M. J Neural Transm 2009 Apr; 116 (4): 451-55. 87.Apathy predicts more severe Parkinsonism in Alzheimer’s disease. Starkstein SE, MERELLO M, Brockman S, Bruce D, Petracca G, Power BD. American Journal of Geriatric Psychiatry 2009 Apr;17 (4): 291-298. 88.Parkinson’s Disease Sleep Scale, sleep logs and actigraphy in the evaluation of sleep in parkinsonian patients. Santiago Perez-Lloret, Malco Rossi, María Inés Nouzeilles, Claudia Trenkwalder, Daniel Cardinali, Marcelo MERELLO. Journal of Neurology, 2009, 256 (9): 1480-4. 89.The syndromal validity and nosological position of apathy in Parkinson’s disease. Starkstein SE, MERELLO M, Jorge R, Brockman S, Bruce D, Power B. Mov Disord. 2009 Jun 15;24(8):1211-6. PMID: 19412942 90.Does clinical intolerance to a diagnostic acute levodopa challenge differentiate Multiple System Atrophy from PD?. Estévez S, Perez-Lloret S, MERELLO M. International Journal of Neuroscience 2009, 119:1-5. 91.Unveiling the less explored side of Parkinson’s disease. MERELLO M. The Lancet Neurology, 8:887, 2009. 92.Irritability, psychomotor agitation and progressive insomnia induced by bilateral stimulation of the area surrounding the dorsal subthalamic nucleus (zona incerta) in Parkinson's disease patients. MERELLO M, Cavanagh S, Perez-Lloret S, Roldan E, Bruno V, Tenca E, Leiguarda R. Journal of Neurology, 2009, 256 (12): 2091-3. 93.Decision-making in Parkinson’s disease patients with and without pathological gambling. Rossi M, Roldan Gerscovich E, De Achábal D, Cerquetti D, Amengual A, Nouzeilles MI, Perez Lloret S, Fahrer R, Leiguarda R, MERELLO M. European Eur J Neurol. 2010 Jan;17(1):97-102. 94.Activity-rest rhythm abnormalities in Parkinson’s disease patients are related to dopaminergic therapy. Perez-Lloret S, Rossi M, Cardinali D, MERELLO M. International Journal of Neuroscience, 120, 11-16, 2010. 95.Task force report scales to assess dyskinesia in Parkinson’s disease: critique and recommendations. Colosino C, Martínez-Martín P, Gabbrini G, Hauser R, MERELLO M, Miyasaki J, Poewe W, Sampaio C, Rascol O, Stebbins G, Schrag A, Goetz Ch. Movement Disorders 2010 Mar. 22. 96.Pramipexole for depression and motor symptons in Parkinson’s disease: can we kill two birds with one stone? Fernandez H, MERELLO M. Lancet Neurology Published on line May 2010, (10) 70114-9. 97.Kinematic study of whole body center of mass position during gait in Parkinson's disease patients with and without festination. MERELLO M, Fantacone N, Balej J. Mov Disord. 2010,25:739-46. 98.Finite dimensional structure of the GPI discharge in patients with Parkinson’s disease. Andres D, Cerquetti D, MERELLO M. International Journal of Neural Systems, 2010; 21(2): 1-12. 99.Progressive Parkinsonism, oculomotor abnormalities and autonomic dysfunction: clinicopathological case. Fabrini G, MERELLO M, Evans A, Holton J, Williams D. Mov Disord. 2011 Feb 15;26(3):424-9. 100.Turbulence in Globus pallidum neurons in patients with Parkinson's disease: exponential decay of the power spectrum. Andrés DS; Cerquetti D; MERELLO, M. 2011. Journal of Neuroscience Methods. (in press) Online publication complete: 21-FEB-2011. 101.Finite dimensional structure of the GPI discharge in patients with Parkinson's disease. Andres DS, Cerquetti D, MERELLO M.Int J Neural Syst. 2011 Jun;21(3):175-86. doi: 10.1142/S0129065711002778.PMID: 21656921 [PubMed - indexed for MEDLINE] 102.Inclusion and exclusion criteria for DBS in dystonia. Bronte-Stewart H, Taira T, Valldeoriola F, MERELLO M, Marks WJ Jr, Albanese A, Bressman S, Moro E.Mov Disord. 2011 Jun;26 Suppl 1:S5-16. doi: 10.1002/mds.23482. Review. PMID: 21692112 [PubMed - indexed for MEDLINE] 103.Diagnostic criteria for depression in Parkinson’s disease: a study of symptom patterns using latent class analysis. Starkstein SE, Milan Dragovic, Ricardo Jorge, Simone Brockman, MERELLO M, et al. Mov. Disord. 2011 Jul 7. PMID: 21739470 104.Wearing-off scales in Parkinson´s disease: critique and recommendatons. Antonini A, Martinez-Martin P, Chaudhuri R, MERELLO M, Hauser R, Katzenschlager R, Odin P, Stacy M, Stocchi F, Poewe W, Rascol O, Sampaio Ch, Schrag A, Stebbins G, Goetz Ch. Mov. Disord. 2011 Jul 20 PMID: 21780180 105.Correlation between the Movement Disorders Society Unified Parkinson’s Disease rating scale (MDS-UPDRS) and the Unified Parkinson’s Disease rating scale (UPDRS) during l-dopa acute challenge. MERELLO M, Gerschcovich ER, Ballesteros D, Cerquetti D. Parkinsonism Relat. Disord. 2011 Jul 22 PMID: 21784692 106.Neuronal discharge patterns in the Globus Pallidus pars interna in a patient with Parkinson´s disease and hemiballismus secondary to subthalamotomy. Cerquetti D, Obeso JA, MERELLO M. Exp Brain Res. 2011 Sept;213(4):447-55 107.Lack of Mainteinance of gait pattern as meassured by instrumental methods suggests psychogenic gait. M MERELLO, D Ballesteros, M Rossi, J Arena, M Crespo, A Cervio et al. Functional Neurology 2012; 27:1-8 108.Chen Moro E, MERELLO M Amantadine improves gait in PD patients with STN stimulation Parkinsonism Relat Disord. 2013 Mar;19(3):316-9. doi: 10.1016/j.parkreldis.2012.11.005. Epub 2012 Dec 6.PMID: 23218842 [PubMed - indexed for MEDLINE] 109.Millar Vernetti P, Perez Lloret S, Rossi M, Cerquetti D, MERELLO M. Validation of a new scale to assess olfactory dysfunction in patients with Parkinson's disease. Parkinsonism Relat Disord. 2012 May;18(4):358-61. Doi 10.1016/j.parkreldis.2011.12.001. Epub 2012 Jan 5. PubMed PMID: 22227345. 110.Perez Lloret S, Rossi M, MERELLO M, Rascol O, Cardinali DP. Nonmotor symptoms groups in Parkinson's disease patients: results of a pilot, exploratory study.Parkinsons Dis. 2011;2011:473579. doi: 10.4061/2011/473579. Epub 2011 May 24. PubMed PMID: 21687754; PubMed Central PMCID: PMC3109353. 111. Lloret SP, Nano G, Carrosella A, Gamzu E, MERELLO M. A double-blind,placebo-controlled, randomized, crossover pilot study of the safety and efficacy of multiple doses of intra-oral tropicamide films for the short-term relief of sialorrhea symptoms in Parkinson's disease patients. J Neurol Sci. 2011 Nov15;310(1-2):248-50. doi: 10.1016/j.jns.2011.05.021. Epub 2011 Jun 1. PubMed PMID:21636098. 112.Perez-Lloret S, Nègre-Pagès L, Ojero-Senard A, Damier P, Destée A, Tison F,MERELLO M, Rascol O; COPARK Study Group. Oro-buccal symptoms (dysphagia,dysarthria, and sialorrhea) in patients with Parkinson's disease: preliminaryanalysis from the French COPARK cohort. Eur J Neurol. 2012 Jan;19(1):28-37. doi: 10.1111/j.1468-1331.2011.03402.x. Epub 2011 Apr 1. PubMed PMID: 21453441. 113.Lack of maintenance of gait pattern as measured by instrumental methods suggests psychogenic gait. MERELLO M, Ballesteros D, Rossi M, Arena J, Crespo M, Cervio A, Cuello Oderiz C, Rivero A, Cerquetti D, Risk M, Balej J. Funct Neurol. 2012 Oct-Dec;27(4):217-24. 114.Amantadine improves gait in PD patients with STN stimulation. Chan HF, Kukkle PL, MERELLO M, Lim SY, Poon YY, Moro E. Parkinsonism Relat Disord. 2013 Mar;19(3):316-9. doi: 10.1016/j.parkreldis.2012.11.005. Epub 2012 Dec 6. 115.Two new adenosine receptor antagonists for the treatment of Parkinson's disease: istradefylline versus tozadenant.Perez-Lloret S, MERELLO M. Expert Opin Pharmacother. 2014 Jun;15(8):1097-107. doi: 10.1517/14656566.2014.903924. Epub 2014 Mar 27. PMID: 24673462 [PubMed - in process] 116.Effects of rotigotine on Parkinson's disease-related sleep disturbances.Antonini A, Calandrella D, MERELLO M, Koutsikos K, Pilleri M. Expert Opin Pharmacother. 2013 Dec;14(18):2571-80. doi: 10.1517/14656566.2013.849692. Epub 2013 Oct 18. PMID: 24138154 [PubMed - in process] 117.Long-term efficacy and safety of safinamide as add-on therapy in early Parkinson's disease. Schapira AH, Stocchi F, Borgohain R, Onofrj M, Bhatt M, Lorenzana P, Lucini V, Giuliani R, Anand R; Study 017 Investigators. Eur J Neurol. 2013 Feb;20(2):271-80. doi: 10.1111/j.1468-1331.2012.03840.x. Epub 2012 Sep 12. PMID: 22967035 [PubMed - indexed for MEDLINE] 118.Diagnostic criteria for depression in Parkinson's disease: a study of symptom patterns using latent class analysis. Starkstein S, Dragovic M, Jorge R, Brockman S, MERELLO M, Robinson RG, Bruce D, Wilson M. Mov Disord. 2011 Oct;26(12):2239-45. doi: 10.1002/mds.23836. Epub 2011 Jul 7. 119.Olfactory Dysfunction Evaluation Is Not Affected by Comorbid Depression in Parkinson's Disease. Rossi M, Perez-Lloret S, Millar Vernetti P, Drucaroff L, Costanzo E, Ballesteros D, Bril A, Cerquetti D, Guinjoan S, MERELLO M.Mov Disord. 2015 Jun 11. doi: 10.1002/mds.26276. [Epub ahead of print] PMID: 26096632 120.Select item 25638494 Piano playing festination as initial symptom of Parkinson's disease. Rossi M, Cerquetti D, MERELLO M. Parkinsonism Relat Disord. 2015 Apr;21(4):417-8. doi: 10.1016/j.parkreldis.2014.12.022. Epub 2015 Jan 7. No abstract available. PMID:25638494 121.Select item 25539892 Management of constipation in Parkinson's disease. Rossi M, MERELLO M, Perez-Lloret S. Expert Opin Pharmacother. 2015 Mar;16(4):547-57. doi: 10.1517/14656566.2015.997211. Epub 2014 Dec 25. Review. PMID: 25539892 122.Teaching NeuroImages: Pisa syndrome in Parkinson disease. Rossi M, MERELLOM.Neurology.2014Nov4;83(19):e177.doi:10.1212/WNL.0000000000000963. No abstract available. 123.Management of constipation in Parkinson's disease. Rossi M, MERELLO M, Perez-Lloret S. Expert Opin Pharmacother. 2015 Mar;16(4):547-57. doi:10.1517/14656566.2015.997211. Epub 2014 Dec 25. Review. PMID: 25539892. 124.Neural code alterations and abnormal time patterns in Parkinson's disease. Andres DS, Cerquetti D, MERELLO M. J Neural Eng. 2015 Apr;12(2):026004. doi: 10.1088/1741-2560/12/2/026004. Epub 2015 Jan 28. PMID: 25629221. 125.Multiple-time-scale framework for understanding the progression of Parkinson's disease. Andres DS, Gomez F, Ferrari FA, Cerquetti D, MERELLO M, Viana R, Stoop R. Phys Rev E Stat Nonlin Soft Matter Phys. 2014 Dec;90(6):062709. Epub 2014 Dec 15.PMID: 25615131. 126.Neuronal Entropy Depends on the Level of Alertness in the Parkinsonian Globus Pallidus in vivo. Andres DS, Cerquetti D, MERELLO M, Stoop R. Front Neurol. 2014 Jun 25;5:96. doi: 10.3389/fneur.2014.00096. eCollection 2014. PMID: 25009529 127.Finite dimensional structure of the GPI discharge in patients with Parkinson's disease. Andres DS, Cerquetti D, MERELLO M. Int J Neural Syst. 2011 Jun;21(3):175-86. doi: 10.1142/S0129065711002778. PMID: 2165692. 128.Turbulence in globus pallidum neurons in patients with Parkinson's disease: exponential decay of the power spectrum. Andres DS, Cerquetti DF, MERELLO M.J.NeurosciMethods.2011Apr15;197(1):14-20.doi:10.1016/j.jneumeth.2011.01.022. Epub 2011 Feb 1. PMID: 21291910 129.Motor features in Parkinson's disease with normal olfactory function 130.Rossi M, Escobar AM, Bril A, Millar Vernetti P, De Palo JI, Cerquetti D, MERELLO M. Mov Disord. 2016 Jun 9. doi: 10.1002/mds.26687. 131.Influence of white matter MRI hyper-intensities on acute l-dopa response in patients with Parkinson's disease. Arena JE, Cerquetti D, Rossi M, Chaves H, Rollan C, Dossi DE, MERELLO M.Parkinsonism Relat Disord. 2016 Mar;24:126-8. doi: 10.1016/j.parkreldis.2016.01.017. Epub 2016 Jan 20. 132.Comparison of Olfactory Identification Patterns among Parkinson's Disease Patients from Different Countries. Millar Vernetti P, Rossi M, Cerquetti D, Perez Lloret S, MERELLO M. Chem Senses. 2016 Jan;41(1):77-83. doi: 10.1093/chemse/bjv062. Epub 2015 Oct 28 133.The impact of emotional distress on motor blocks and festination in Parkinson's disease. Starkstein S, Dragovic M, Brockman S, Wilson M, Bruno V, MERELLO M. J Neuropsychiatry Clin Neurosci. 2015;27(2):121-6. doi: 10.1176/appi.neuropsych.13030053. 134.Motor features in Parkinson's disease with normal olfactory function Rossi M, Escobar AM, Bril A, Millar Vernetti P, De Palo JI, Cerquetti D, MERELLO M. Mov Disord. 2016 Jun 9. doi: 10.1002/mds.26687. 135.Influence of white matter MRI hyper-intensities on acute l-dopa response in patients with Parkinson's disease. Arena JE, Cerquetti D, Rossi M, Chaves H, Rollan C, Dossi DE, MERELLO M.Parkinsonism Relat Disord. 2016 Mar;24:126-8. doi: 10.1016/j.parkreldis.2016.01.017. Epub 2016 Jan 20. 136.Comparison of Olfactory Identification Patterns among Parkinson's Disease Patients from Different Countries.Millar Vernetti P, Rossi M, Cerquetti D, Perez Lloret S, MERELLO M. Chem Senses. 2016 Jan;41(1):77-83. doi: 10.1093/chemse/bjv062. Epub 2015 Oct 28 137.The impact of emotional distress on motor blocks and festination in Parkinson's disease. Starkstein S, Dragovic M, Brockman S, Wilson M, Bruno V, MERELLO M. J Neuropsychiatry Clin Neurosci. 2015;27(2):121-6. doi: 10.1176/appi.neuropsych.13030053. 138.Two new adenosine receptor antagonists for the treatment of Parkinson's disease: istradefylline versus tozadenant.Perez-Lloret S, MERELLO M. Expert Opin Pharmacother. 2014 Jun;15(8):1097-107. doi: 10.1517/14656566.2014.903924. Epub 2014 Mar 27. PMID: 24673462 139.Autosomal dominant cerebellar ataxias: a systematic review of clinical features.Rossi M, Perez-Lloret S, Doldan L, Cerquetti D, Balej J, Millar Vernetti P, Hawkes H, Cammarota A, MERELLO M. Eur J Neurol. 2014 Apr;21(4):607-15. Review. PMID: 24765663 140.Olfactory Dysfunction Evaluation Is Not Affected by Comorbid Depression in Parkinson's Disease. Rossi M, Perez-Lloret S, Millar Vernetti P, Drucaroff L, Costanzo E, Ballesteros D, Bril A, Cerquetti D, Guinjoan S, MERELLO M.Mov Disord. 2015 Jun 11. doi: 10.1002/mds.26276. [Epub ahead of print] PMID: 26096632 141.Piano playing festination as initial symptom of Parkinson's disease. Rossi M, Cerquetti D, MERELLO M. Parkinsonism Relat Disord. 2015 Apr;21(4):417-8. doi: 10.1016/j.parkreldis.2014.12.022. Epub 2015 Jan 7. No abstract available. PMID:25638494 142.Management of constipation in Parkinson's disease. Rossi M, MERELLO M, Perez-Lloret S. Expert Opin Pharmacother. 2015 Mar;16(4):547-57. doi: 10.1517/14656566.2015.997211. Epub 2014 Dec 25. Review. PMID: 25539892 143.Teaching NeuroImages: Pisa syndrome in Parkinson disease. Rossi M, MERELLO M. Neurology.2014Nov4; 83(19): e177. doi:101212/WNL.0000000000000963. 144.Neural code alterations and abnormal time patterns in Parkinson's disease. Andres DS, Cerquetti D, MERELLO M. J Neural Eng. 2015 Apr;12(2):026004. doi: 10.1088/1741-2560/12/2/026004. Epub 2015 Jan 28. PMID: 25629221. 145.Multiple-time-scale framework for understanding the progression of Parkinson's disease. Andres DS, Gomez F, Ferrari FA, Cerquetti D, MERELLO M, Viana R, Stoop R. Phys Rev E Stat Nonlin Soft Matter Phys. 2014 Dec;90(6):062709. Epub 2014 Dec 15.PMID: 25615131. 146.Neuronal Entropy Depends on the Level of Alertness in the Parkinsonian Globus Pallidus in vivo. Andres DS, Cerquetti D, MERELLO M, Stoop R. Front Neurol. 2014 Jun 25;5:96. doi: 10.3389/fneur.2014.00096. eCollection 2014. PMID: 25009529 147. Autosomal dominant cerebellar ataxias: a systematic review of clinical features. Rossi M., Perez-Lloret S., Doldan L., Cerquetti D., Balej J., Millar P., Hawkes M., Cammarota A., MERELLO M. Eur J Neurol. 2014 Apr;21(4):607-15. Epub 2014 Feb 12. Review. 148.JE Arena, D Cerquetti, M Rossi, H Chaves, C Rollan, DE Dossi, M MERELLO Influence of white matter MRI hyper-intensities on acute l-dopa response in patients with Parkinson's disease Parkinsonism & related disorders 24, 126-1281. 2016 149.Ropinirole‐Induced Anterocollis in Parkinson's disease L Ameghino, M Rossi, Á Cammarota, M MERELLO Movement Disorders Clinical Practice 3 (1), 91-92 1. 2016 150.Comparison of Olfactory Identification Patterns among Parkinson’s Disease Patients from Different Countries PM Vernetti, M Rossi, D Cerquetti, SP Lloret, M MERELLO Chemical senses 41 (1), 77-83 151.Rodríguez‐Blázquez, Carmen; Alvarez, Mario; Arakaki, Tomoko; Campos Arillo, Víctor; Chaná, Pedro; Fernández, William; Garretto, Nélida; Martínez‐Castrillo, Juan Carlos; Rodríguez‐Violante, Mayela; Serrano‐Dueñas, Marcos; Self‐assessment of disability in Parkinson's disease: The MDS‐UPDRS Part II vs. clinician‐based ratings,Movement Disorders Clinical Practice,2016,Wiley 152.Rossi, Malco; Cerquetti, Daniel; Mandolesi, Jorge; MERELLO, Marcelo; ,"Thalamotomy, pallidotomy and subthalamotomy in the management of Parkinson’s disease". Parkinson's Disease: Current and Future Therapeutics and Clinical Trials,175,2016, Cambridge University Press 153.Rossi, Malco; Medina Escobar, Alex; Radrizzani, Martin; Tenembaum, Silvia; Perandones, Claudia; MERELLO, Marcelo; ,Dystonia in a Patient with Autosomal‐Dominant Progressive External Ophthalmoplegia Type 1 Caused by Mutation in the POLG Gene,Movement Disorders Clinical Practice,2016,Wiley Online Library 154.Rossi, Malco; Wilken, Miguel; Morisset, Pierre; Fariña, Sofia; Cerquetti, Daniel; MERELLO, Marcelo. ,Facial tremors in patients with and without parkinsonism, Neurological Sciences,37,12,1999-2002,2016, Springer 155.Bhatia, Kailash; MERELLO, Marcelo; ,New Developments for MDCP, Movement Disorders Clinical Practice,3,1,3-3,2016,Wiley Online Library 156.MERELLO, Marcelo. α‐Synuclein as a Biomarker for Parkinson's Disease: A Gut Feeling. Movement Disorders Clinical Practice,3,5,519-520,2016,Wiley Online Library 157.Martínez-Martín, Pablo; Rojo-Abuin, Jose Manuel; Rodríguez-Violante, Mayela; Serrano-Dueñas, Marcos; Garretto, Nélida; Martínez-Castrillo, Juan Carlos; Arillo, Víctor Campos; Fernández, William; Chaná-Cuevas, Pedro; Arakaki, Tomoko; ,Analysis of four scales for global severity evaluation in Parkinson’s disease. Nature Parkinson's Disease ,2,16007,2016, Nature Publishing Group 158.Rossi M, Cammarota A, MERELLO M, Nogues M. A treatable rare cause of chorea. Neurology. 2018. 159.Rossi M, Cesarini M, Gatto EM, Cammarota A, MERELLO M. A treatable rare cause of progressive ataxia and palatal tremor. Tremor and Other Hyperkinet Mov (N Y). 2018. DOI: 10.7916/D8X07Q2N 160.Rossi M, Balint B, Millar Vernetti P, Bhatia KP, MERELLO M. Genetic dystonia-ataxia syndromes: clinical spectrum, diagnostic approach and treatment options. Mov Disord Clin Pract. 2018. https://doi.org/10.1002/mdc3.12635 161.Rossi M, Bruno V, Arena J, Cammarota A, MERELLO M. Challenges in PD patient management after DBS: A Pragmatic Review. Mov Disord Clin Pract. 2018. https://doi.org/10.1002/mdc3.12592 162.Terroba Chambi C, Bruno V, Medina-Escobar A, Nanni F, Cerquetti D, Rossi M, MERELLO M. Open-access electronic diary for motor fluctuation and dyskinesia evaluation in Parkinson disease: comparison with paper diary. Clin Neuropharmacol. 2018. Jan/Feb;41(1):20-22. 163.Rossi M, Medina Escobar A, Ameghino L, MERELLO M. Expanding the phenotype of phosphomannomutase-2 gene congenital disorder of glycosylation: Cervical dystonia. J Neurol Sci. 2017; 378:52-54 164.Rossi M, Medina Escobar A, Radrizzani M, Tenembaum S, Perandones C, MERELLO M. Dystonia in a Patient with Autosomal‐Dominant Progressive External Ophthalmoplegia Type 1 Caused by Mutation in the POLG Gene. Mov Disord Clin Pract. 2017;4(2):266-269. 165.Terroba Chambi C, Rossi M, Bril A, Millar Vernetti P, Cerquetti D, Cammarota A, MERELLO M. Diagnostic value of combined acute levodopa challenge and olfactory testing to predict Parkinson's disease. Mov Disord Clin Pract. 2017. DOI: 10.1002/mdc3.12517 166.Ameghino L1, Bruno V2, MERELLO M. Postural Disorders and Antiparkinsonian Treatments in Parkinson Disease: An Exploratory Case-Control Study. Clin Neuropharmacol. 2018 Jul/Aug;41(4):123-128. doi: 10.1097/WNF.0000000000000285. 167.Rossi M, Escobar AM, Bril A, Millar Vernetti P, De Palo JI, Cerquetti D, MERELLO M. Motor features in Parkinson's disease with normal olfactory function. Mov Disord. 2016;31 (9):1414-7. 168.Rossi M, Wilken M, Morisset P, Fariña S, Cerquetti D, MERELLO M. Facial tremors in patients with and without parkinsonism. Neurol Sci. 2016 Dec; 37 (12):1999-2002. 169.Millar Vernetti P, Rossi M, Cerquetti D, Perez Lloret S, MERELLO M. Comparison of olfactory identification patterns among Parkinson´s disease patients from different countries. Chem Senses. 2016 Jan; 41(1):77-83. 170.Ameghino L, Rossi M, MERELLO M. How Do I Examine Postural Disorders in Parkinson's Disease? Mov Disord Clin Pract. 2016;3 (6):626 171.Ameghino L, Rossi M, Cammarota A, MERELLO M. Ropinirole‐Induced Anterocollis in Parkinson's Disease. Mov Disord Clin Pract. 2016;3 (1):91-92. 172.Arena JE, Cerquetti D, Rossi M, Chaves H, Rollan C, Dossi DE, MERELLO M. Influence of white matter MRI hyper-intensities on acute l-dopa response in patients with Parkinson's disease. Parkinsonism Relat Disord. 2016; 24:126-8 173.Ameghino L, Rossi MD, Cerquetti D, MERELLO M. Is tremor related to celiac disease? World J Gastroenterol. 2017 Jun 14;23(22):4132-4134. doi: 10.3748/wjg.v23.i22.4132. 174.Daniela Andres. MERELLO M. Olivier Darbin. Pathophysiology of the Basal Ganglia and Movement Disorders: Gaining New Insights from Modeling and Experimentation, to Influence the Clinic. Frontiers in human neuroscience. doi: 10.3389/fnhum.2017.00466 Sept. 2017. 175. Bril A, Perez Lloret S, Rossi M, Fariña S, Morisset P, Sorrentino L, Iglesias M, Medina Escobar A, Millar Vernetti P, Cerquetti D, MERELLO M. A multifactorial study on nutritional status, binge eating and physical activity as main factors directly influencing body weight in Parkinson’s disease. Nature Parkinson’s Disease. 2017;3 (17). doi:10.1038/s41531-017-0018-0 176. Wilken M, Bruno V, Rossi M, Ameghino L, Deuschl G, MERELLO M. Sensitivity and specificity of different hand positions to assess upper limb rest tremor Mov Disord. 2019 Apr;34(4):575-579. doi: 10.1002/mds.27648. Epub 2019 Feb 20. PMID: 30788866 177. Wilken M, Rossi M, Rivero AD, Hallett M, MERELLO M. Re-emergent tremor provocation. Parkinsonism Relat Disord. 2019 Sep;66:241-244. doi: 10.1016/j.parkreldis.2019.08.015. Epub 2019 Aug 26. 178. Wilken M, Rossi MD, Rivero AD, Hallett M, MERELLO M. Latency of re-emergent tremor in Parkinson's disease is influenced by levodopa. Parkinsonism Relat Disord. 2019 Apr;61:166-169. doi: 10.1016/j.parkreldis.2018.10.019. Epub 2018 Oct 15. 179. Rossi M, Wilken M, Morisset P, Fariña S, Cerquetti D, MERELLO M. Facial tremors in patients with and without parkinsonism. Neurol Sci. 2016 Dec;37(12):1999-2002. Epub 2016 Jul 28. 180. Terroba-Chambi C, Bruno V, Millar-Vernetti P, Bruce D, Brockman S, MERELLO M, Starkstein S. Design and validation of a new instrument to assess fear of falling in Parkinson's disease. Mov Disord. 2019 Aug 23. doi: 10.1002/mds.27820. 181. Rossi M, Bruno V, Arena J, Cammarota Á, MERELLO M. Challenges in PD Patient Management After DBS: A Pragmatic Review. Mov Disord Clin Pract. 2018 Feb 28;5(3):246-254. doi: 10.1002/mdc3.12592. eCollection 2018 May-Jun. Review. 182. Rossi M, Balint B, Millar Vernetti P, Bhatia KP, MERELLO M. Genetic Dystonia-ataxia Syndromes: Clinical Spectrum, Diagnostic Approach, and Treatment Options. Mov Disord Clin Pract. 2018 Jul 3;5(4):373-382. doi: 10.1002/mdc3.12635. eCollection 2018 Jul-Aug. Review. 183. MERELLO M.The Dark Side of Globalization: Lack of Universal Levodopa Availability. Mov Disord Clin Pract. 2018 Nov 16;6(1):7-8. doi: 10.1002/mdc3.12704. eCollection 2019 Jan. No abstract available. PMID: 30746409 184. Mulroy E, Balint B, Adams ME, Campion T, MERELLO M, Bhatia KP. Animals in the Brain. Mov Disord Clin Pract. 2019 Feb 28;6(3):189-198. doi: 10.1002/mdc3.12734. eCollection 2019 Mar. Review. PMID: 30949548. 185. Rossi M, Cerquetti D, Cammarota A, MERELLO M.Tourette syndrome: Clinical benefit with unilateral stimulation after bilateral pallidal implant.Mov Disord. 2019 Apr;34(4):580-582. doi: 10.1002/mds.27636. 186. Bhatia K, MERELLO M. Response from the Editors RE: DUOPA® is an Excellent Alternative Treatment but with Some Caveats. Mov Disord Clin Pract. 2019 Mar 27;6(4):338. doi: 10.1002/mdc3.12737. eCollection 2019 Apr. No abstract available. 187. Ameghino L, Marrodan M, Lang AE, MERELLO M. Isolated lingual myoclonus in an HIV patient. Parkinsonism Relat Disord. 2019 Apr;61:241-244. doi: 10.1016/j.parkreldis.2018.10.020. Epub 2018 Oct 15. No abstract available. PMID: 31036159 188: Stoessl AJ, Bhatia KP, MERELLO M. Movement Disorders in the World of COVID-19. Mov Disord. 2020 May;35(5):709-710. doi: 10.1002/mds.28069. Epub 2020 Apr 16. PMID: 32250468. 189. Fasano A, Antonini A, Katzenschlager R, Krack P, Odin P, Evans AH, Foltynie T, Volkmann J, MERELLO M. Management of Advanced Therapies in Parkinson's Disease Patients in Times of Humanitarian Crisis: The COVID-19 Experience. Mov Disord Clin Pract. 2020 May 4;7(4):361-372. doi: 10.1002/mdc3.12965. PMID: 32373652; PMCID: PMC7197306. 190: Rossi M, Farcy N, Starkstein SE, MERELLO M. Nosology and Phenomenology of Psychosis in Movement Disorders. Mov Disord Clin Pract. 2020 Jan 7;7(2):140-153.doi: 10.1002/mdc3.12882. PMID: 32071931; PMCID: PMC7011839. 191.Bhatia K, MERELLO M. Response from the Editors RE: DUOPA® is an Excellent Alternative Treatment but with Some Caveats. Mov Disord Clin Pract. 2019 Mar7;6(4):338. doi: 10.1002/mdc3.12737. PMID: 31061848; PMCID: PMC6476624. 192: Stoessl AJ, Bhatia KP, MERELLO M. Movement Disorders in the World ofCOVID-19. Mov Disord Clin Pract. 2020 Apr 16;7(4):355-356. doi: 10.1002/mdc3.12952. PMID: 32373650; PMCID: PMC7197302. 194. Millar Vernetti P, Rossi M, MERELLO M. Parkin Pleiotropy: Extremely Atypical Phenotypes in Patients With Compound Heterozygous Mutations. Tremor Other Hyperkinet Mov (N Y). 2020;10:26. Published 2020 Aug 13. doi:10.5334/tohm.55 195. Rossi M, van der Veen S, MERELLO M, Tijssen MAJ, van de Warrenburg B. Myoclonus-Ataxia Syndromes: A Diagnostic Approach. Mov Disord Clin Pract. 2020 Nov 3;8(1):9-24. doi: 10.1002/mdc3.13106. PMID: 33426154; PMCID: PMC7780951. 196. MERELLO M, Bhatia KP, Obeso JA. SARS-CoV-2 and the risk of Parkinson's disease: facts and fantasy. Lancet Neurol. 2021 Feb;20(2):94-95. doi: 10.1016/S1474-4422(20)30442-7. Epub 2020 Nov 27. PMID: 33253627; PMCID: PMC7834123. 197. Fasano A, MERELLO M. Fading of Deep Brain Stimulation Efficacy Versus Disease Progression: Untangling a Gordian Knot. Mov Disord Clin Pract. 2020 Sep 21;7(7):747-749. doi: 10.1002/mdc3.13041. PMID: 33043072; PMCID: PMC7533966. 198. Terroba-Chambi C, Abulafia C, Vigo DE, MERELLO M. Heart Rate Variability and Mild Cognitive Impairment in Parkinson's Disease. Mov Disord. 2020 Dec;35(12):2354-2355. doi: 10.1002/mds.28234. Epub 2020 Sep 21. PMID: 32956543. 199. Palma JA, Vernetti PM, Perez MA, Krismer F, Seppi K, Fanciulli A, Singer W, Low P, Biaggioni I, Norcliffe-Kaufmann L, Pellecchia MT, Martí MJ, Kim HJ, MERELLO M, Stankovic I, Poewe W, Betensky R, Wenning G, Kaufmann H. Limitations of the Unified Multiple System Atrophy Rating Scale as outcome measure for clinical trials and a roadmap for improvement. Clin Auton Res. 2021 Feb 7:1–8. doi: 10.1007/s10286-021-00782-w. Epub ahead of print. PMID: 33554315; PMCID: PMC7868077. 200. Rossi M, Bruno V, Arena J, Cammarota Á, MERELLO M. Challenges in PD Patient Management After DBS: A Pragmatic Review. Mov Disord Clin Pract. 2018 Feb 28;5(3):246-254. doi: 10.1002/mdc3.12592. PMID: 30363375; PMCID: PMC6174419. 201. Rossi M, Wainsztein N, MERELLO M. Cardiac Involvement in Movement Disorders. Mov Disord Clin Pract. 2021 Apr 7;8(5):651-668. doi: 10.1002/mdc3.13188. PMID: 34307738; PMCID: PMC8287161. 202. Gisatulin M, Rossi M, Perandones C, Klein C, Lohmann K, MERELLO M. Involuntary moaning in a Hispanic family with eight affected members. Parkinsonism Relat Disord. 2021 Mar 26:S1353-8020(21)00116-4. doi: 10.1016/j.parkreldis.2021.03.023. Epub ahead of print. PMID: 33814296. 203. Terroba-Chambi C, Bruno V, Vigo DE, MERELLO M. Heart rate variability and falls in Huntington's disease. Clin Auton Res. 2021 Apr;31(2):281-292. doi: 10.1007/s10286-020-00669-2. Epub 2020 Feb 6. PMID: 32026136. 204. Malco Rossi, Santiago Perez-Lloret, Marcelo MERELLO. How much time is needed in clinical practice to reach a diagnosis of clinically established Parkinson’s disease? Parkinsonism and Related Disorders 92 (2021) 53–58 205. Millar Vernetti P, Ruiz Yanzi MA, Rossi M, MERELLO M. Genetic Diagnosis in Movement Disorders. Use of Whole-Exome Sequencing in Clinical Practice. Tremor and Other Hyperkinetic Movements. 2022;12(1) 207. Paez-Maggio M, Rossi M, Fazzito L, MERELLO M. Validation of an events exposure questionnaire for individuals living in major cities of Argentina. Eur J Psychotraumatol. 2022 Feb 15;13(1):2031830. doi: 10.1080/20008198.2022.2031830. PMID: 35186218; PMCID: PMC8856068. 208. Tinazzi M, Geroin C, Bhidayasiri R, Bloem BR, Capato T, Djaldetti R, Doherty K, Fasano A, Tibar H, Lopiano L, Margraf NG, MERELLO M, Moreau C, Ugawa Y, Artusi CA; International Parkinson and Movement Disorders Society Task Force on Postural Abnormalities. Task Force Consensus on Nosology and Cut-Off Values for Axial Postural Abnormalities in Parkinsonism. Mov Disord Clin Pract. 2022 May 9;9(5):594-603. doi: 10.1002/mdc3.13460. PMID: 35844289; PMCID: PMC9274349. 209.Paez-Maggio M, Rossi M, Fazzito L, MERELLO M. Validation of an events exposure questionnaire for individuals living in major cities of Argentina. Eur J Psychotraumatol. 2022 Feb 15;13(1):2031830. doi: 10.1080/20008198.2022.2031830. PMID: 35186218; PMCID: PMC8856068. 210. Castillo-Torres SA, Viti M, Martínez-Villota VA, Rossi M, MERELLO M. Multiple system atrophy laryngeal stridor treated with radiofrequency-assisted posterior cordotomy and arytenoidectomy. Clin Auton Res. 2022 Aug;32(4):303-306. doi: 10.1007/s10286-022-00876-z. Epub 2022 Jul 19. PMID: 35852669. 211. Rossi M, Castillo-Torres SA, MERELLO M. Early motor response to dopamine replacement therapy in Parkinson's disease patients carrying GBA variants. J Neurol Sci. 2022 Jul 25;440:120354. doi: 10.1016/j.jns.2022.120354. Epub ahead of print. PMID: 35907343. 212. Martínez-Villota VA, Terroba-Chambi C, Castillo-Torres SA, Rossi M, MERELLO M. Clinical correlates of fear of falling in progressive supranuclear palsy and multiple system atrophy. Eur J Neurol. 2023 Aug;30(8):2261-2266. doi: 10.1111/ene.15864. Epub 2023 May 29. PMID: 37183570. 213. Vollstedt EJ, Schaake S, Lohmann K, Padmanabhan S, Brice A, Lesage S, Tesson C, Vidailhet M, Wurster I, Hentati F, Mirelman A, Giladi N, Marder K, Waters C, Fahn S, Kasten M, Brüggemann N, Borsche M, Foroud T, Tolosa E, Garrido A, Annesi G, Gagliardi M, Bozi M, Stefanis L, Ferreira JJ, Correia Guedes L, Avenali M, Petrucci S, Clark L, Fedotova EY, Abramycheva NY, Alvarez V, Menéndez-González M, Jesús Maestre S, Gómez-Garre P, Mir P, Belin AC, Ran C, Lin CH, Kuo MC, Crosiers D, Wszolek ZK, Ross OA, Jankovic J, Nishioka K, Funayama M, Clarimon J, Williams-Gray CH, Camacho M, Cornejo-Olivas M, Torres-Ramirez L, Wu YR, Lee-Chen GJ, Morgadinho A, Pulkes T, Termsarasab P, Berg D, Kuhlenbäumer G, Kühn AA, Borngräber F, de Michele G, De Rosa A, Zimprich A, Puschmann A, Mellick GD, Dorszewska J, Carr J, Ferese R, Gambardella S, Chase B, Markopoulou K, Satake W, Toda T, Rossi M, MERELLO M, Lynch T, Olszewska DA, Lim SY, Ahmad-Annuar A, Tan AH, Al-Mubarak B, Hanagasi H, Koziorowski D, Ertan S, Genç G, de Carvalho Aguiar P, Barkhuizen M, Pimentel MMG, Saunders-Pullman R, van de Warrenburg B, Bressman S, Toft M, Appel-Cresswell S, Lang AE, Skorvanek M, Boon AJW, Krüger R, Sammler EM, Tumas V, Zhang BR, Garraux G, Chung SJ, Kim YJ, Winkelmann J, Sue CM, Tan EK, Damásio J, Klivényi P, Kostic VS, Arkadir D, Martikainen M, Borges V, Hertz JM, Brighina L, Spitz M, Suchowersky O, Riess O, Das P, Mollenhauer B, Gatto EM, Petersen MS, Hattori N, Wu RM, Illarioshkin SN, Valente EM, Aasly JO, Aasly A, Alcalay RN, Thaler A, Farrer MJ, Brockmann K, Corvol JC, Klein C; MJFF Global Genetic Parkinson's Disease Study Group. Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort. Mov Disord. 2023 Feb;38(2):286-303. doi: 10.1002/mds.29288. Epub 2023 Jan 24. PMID: 36692014. 214. Castillo-Torres SA, Lees AJ, MERELLO M. Intermittent Apomorphine Use for off Period Rescue in Parkinson's Disease: A Pragmatic Review of over Three Decades of Clinical Experience. Mov Disord Clin Pract. 2022 Oct 27;10(2):190-208. doi: 10.1002/mdc3.13593. PMID: 36825043; PMCID: PMC9941929. 215. Vollstedt EJ, Schaake S, Lohmann K, Padmanabhan S, Brice A, Lesage S, Tesson C, Vidailhet M, Wurster I, Hentati F, Mirelman A, Giladi N, Marder K, Waters C, Fahn S, Kasten M, Brüggemann N, Borsche M, Foroud T, Tolosa E, Garrido A, Annesi G, Gagliardi M, Bozi M, Stefanis L, Ferreira JJ, Correia Guedes L, Avenali M, Petrucci S, Clark L, Fedotova EY, Abramycheva NY, Alvarez V, Menéndez-González M, Jesús Maestre S, Gómez-Garre P, Mir P, Belin AC, Ran C, Lin CH, Kuo MC, Crosiers D, Wszolek ZK, Ross OA, Jankovic J, Nishioka K, Funayama M, Clarimon J, Williams-Gray CH, Camacho M, Cornejo-Olivas M, Torres-Ramirez L, Wu YR, Lee-Chen GJ, Morgadinho A, Pulkes T, Termsarasab P, Berg D, Kuhlenbäumer G, Kühn AA, Borngräber F, de Michele G, De Rosa A, Zimprich A, Puschmann A, Mellick GD, Dorszewska J, Carr J, Ferese R, Gambardella S, Chase B, Markopoulou K, Satake W, Toda T, Rossi M, MERELLO M, Lynch T, Olszewska DA, Lim SY, Ahmad-Annuar A, Tan AH, Al-Mubarak B, Hanagasi H, Koziorowski D, Ertan S, Genç G, de Carvalho Aguiar P, Barkhuizen M, Pimentel MMG, Saunders-Pullman R, van de Warrenburg B, Bressman S, Toft M, Appel-Cresswell S, Lang AE, Skorvanek M, Boon AJW, Krüger R, Sammler EM, Tumas V, Zhang BR, Garraux G, Chung SJ, Kim YJ, Winkelmann J, Sue CM, Tan EK, Damásio J, Klivényi P, Kostic VS, Arkadir D, Martikainen M, Borges V, Hertz JM, Brighina L, Spitz M, Suchowersky O, Riess O, Das P, Mollenhauer B, Gatto EM, Petersen MS, Hattori N, Wu RM, Illarioshkin SN, Valente EM, Aasly JO, Aasly A, Alcalay RN, Thaler A, Farrer MJ, Brockmann K, Corvol JC, Klein C; MJFF Global Genetic Parkinson's Disease Study Group. Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort. Mov Disord. 2023 Feb;38(2):286-303. doi: 10.1002/mds.29288. Epub 2023 Jan 24. PMID: 36692014. 216. Bhatia K, MERELLO M. Introducing Neuromodulation Letters (NM Letters). Mov Disord Clin Pract. 2023 May 5;10(6):867. doi: 10.1002/mdc3.13756. PMID: 37332635; PMCID: PMC10272895. 217. MERELLO M, Bhatia K. Editors Note: Looking Forward, Looking Back. Mov Disord Clin Pract. 2022 Dec 9;10(1):6. doi: 10.1002/mdc3.13629. PMID: 36704079; PMCID: PMC9847304. 218. Pal G, Cook L, Schulze J, Verbrugge J, Alcalay RN, MERELLO M, Sue CM, Bardien S, Bonifati V, Chung SJ, Foroud T, Gatto E, Hall A, Hattori N, Lynch T, Marder K, Mascalzoni D, Novaković I, Thaler A, Raymond D, Salari M, Shalash A, Suchowersky O, Mencacci NE, Simuni T, Saunders-Pullman R, Klein C. Genetic Testing in Parkinson's Disease. Mov Disord. 2023 Aug;38(8):1384-1396. doi: 10.1002/mds.29500. Epub 2023 Jun 27. PMID: 37365908. 219. Ferreirós A, Castillo-Torres SA, MERELLO M. Motor assessment of patients with multiple system atrophy: underuse of the Unified Multiple System Atrophy Rating Scale (UMSARS). Clin Auton Res. 2023 Apr;33(2):143-148. doi: 10.1007/s10286-023-00934-0. Epub 2023 Mar 27. PMID: 36971870. 220. Martínez-Villota VA, Castillo-Torres SA, Rossi M, MERELLO M. Rapidly Progressive Atypical Parkinsonism as a Presenting Feature of ATX-CACNA1G (SCA42). Mov Disord Clin Pract. 2023 Mar 16;10(4):713-715. doi: 10.1002/mdc3.13704. PMID: 37070041; PMCID: PMC10105115. 221. Geroin C, Artusi CA, Nonnekes J, Aquino C, Garg D, Dale ML, Schlosser D, Lai Y, Al-Wardat M, Salari M, Wolke R, Labou VT, Imbalzano G, Camozzi S, MERELLO M, Bloem BR, Capato T, Djaldetti R, Doherty K, Fasano A, Tibar H, Lopiano L, Margraf NG, Moreau C, Ugawa Y, Bhidayasiri R, Tinazzi M; International Parkinson and Movement Disorders Society Task Force on Postural Abnormalities. Axial Postural Abnormalities in Parkinsonism: Gaps in Predictors, Pathophysiology, and Management. Mov Disord. 2023 May;38(5):732-739. doi: 10.1002/mds.29377. Epub 2023 Apr 20. PMID: 37081741. 222. Castillo-Torres SA, Rossi M, Paez-Maggio M, Capparelli F, Gómez-Arevalo G, MERELLO M. Early-Onset Dementia-Parkinsonism with Rapid Development of Motor Fluctuations and Dyskinesia Due to PSEN1 G206V Pathogenic Variant. Mov Disord Clin Pract. 2022 Nov 22;10(2):335-337. doi: 10.1002/mdc3.13617. PMID: 36825052; PMCID: PMC9941923. 223. Saunders-Pullman R, Raymond D, Ortega RA, Shalash A, Gatto E, Salari M, Markgraf M, Alcalay RN, Mascalzoni D, Mencacci NE, Bonifati V, MERELLO M, Chung SJ, Novakovic I, Bardien S, Pal G, Hall A, Hattori N, Lynch T, Thaler A, Sue CM, Foroud T, Verbrugge J, Schulze J, Cook L, Marder K, Suchowersky O, Klein C, Simuni T. International Genetic Testing and Counseling Practices for Parkinson's Disease. Mov Disord. 2023 Aug;38(8):1527-1535. doi: 10.1002/mds.29442. Epub 2023 Jun 13. PMID: 37310233; PMCID: PMC10461455. 224. Ana Westenberger, Volha Skrahina, Tatiana Usnich, Christian Beetz, Eva-Juliane Vollstedt, Björn-Hergen Laabs, Jefri J Paul, Filipa Curado, Snezana Skobalj, Hanaa Gaber, Maria Olmedillas, Xenia Bogdanovic, Najim Ameziane, Nathalie Schell, Jan Olav Aasly, Mitra Afshari, Pinky Agarwal, Jason Aldred, Fernando Alonso-Frech, Roderick Anderson, Rui Araújo, David Arkadir, Micol Avenali, Mehmet Balal, Sandra Benizri, Sagari Bette, Perminder Bhatia, Michael Bonello, Pedro Braga-Neto, Sarah Brauneis, Francisco Eduardo Costa Cardoso, Francesco Cavallieri, Joseph Classen, Lisa Cohen, Della Coletta, David Crosiers, Paskal Cullufi, Khashayar Dashtipour, Meltem Demirkiran, Patricia de Carvalho Aguiar, Anna De Rosa, Ruth Djaldetti, Okan Dogu, Maria Gabriela dos Santos Ghilardi, Carsten Eggers, Bulent Elibol, Aaron Ellenbogen, Sibel Ertan, Giorgio Fabiani, Björn H Falkenburger, Simon Farrow, Tsviya Fay-Karmon, Gerald J Ferencz, Erich Talamoni Fonoff, Yara Dadalti Fragoso, Gençer Genç, Arantza Gorospe, Francisco Grandas, Doreen Gruber, Mark Gudesblatt, Tanya Gurevich, Johann Hagenah, Hasmet A Hanagasi, Sharon Hassin-Baer, Robert A Hauser, Jorge Hernández-Vara, Birgit Herting, Vanessa K Hinson, Elliot Hogg, Michele T Hu, Eduardo Hummelgen, Kelly Hussey, Jon Infante, Stuart H Isaacson, Serge Jauma, Natalia Koleva-Alazeh, Gregor Kuhlenbäumer, Andrea Kühn, Irene Litvan, Lydia López-Manzanares, McKenzie Luxmore, Sujeena Manandhar, Veronique Marcaud, Katerina Markopoulou, Connie Marras, Mark McKenzie, Michele Matarazzo, Marcelo MERELLO, Brit Mollenhauer, John C Morgan, Stephen Mullin, Thomas Musacchio, Bennett Myers, Anna Negrotti, Anette Nieves, Zeev Nitsan, Nader Oskooilar, Özgür Öztop-Çakmak, Gian Pal, Nicola Pavese, Antonio Percesepe, Tommaso Piccoli, Carolina Pinto de Souza, Tino Prell, Mark Pulera, Jason Raw, Kathrin Reetz, Johnathan Reiner, David Rosenberg, Marta Ruiz-Lopez, Javier Ruiz Martinez, Esther Sammler, Bruno Lopes Santos-Lobato, Rachel Saunders-Pullman, Ilana Schlesinger, Christine M Schofield, Artur F Schumacher-Schuh, Burton Scott, Ángel Sesar, Stuart J Shafer, Ray Sheridan, Monty Silverdale, Rani Sophia, Mariana Spitz, Pantelis Stathis, Fabrizio Stocchi, Michele Tagliati, Yen F Tai, Annelies Terwecoren, Sven Thonke, Lars Tönges, Giulia Toschi, Vitor Tumas, Peter Paul Urban, Laura Vacca, Wim Vandenberghe, Enza Maria Valente, Franco Valzania, Lydia Vela-Desojo, Caroline Weill, David Weise, Joanne Wojcieszek, Martin Wolz, Gilad Yahalom, Gul Yalcin-Cakmakli, Simone Zittel, Yair Zlotnik, Krishna K Kandaswamy, Alexander Balck, Henrike Hanssen, Max Borsche, Lara M Lange, Ilona Csoti, Katja Lohmann, Meike Kasten, Norbert Brüggemann, Arndt Rolfs, Christine Klein, Peter Bauer, Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson’s disease study, Brain, Volume 147, Issue 8, August 2024, Pages 2652–2667, https://doi.org/10.1093/brain/awae188 225. Kukkle PL, Garg D, MERELLO M. Continuous Subcutaneous Infusion Delivery of Apomorphine in Parkinson's Disease: A Systematic Review. Mov Disord Clin Pract. 2023 Jun 26;10(9):1253-1267. doi: 10.1002/mdc3.13810. PMID: 37772305; PMCID: PMC10525070. 226.Artusi CA, Geroin C, Nonnekes J, Aquino C, Garg D, Dale ML, Schlosser D, Lai Y, Al-Wardat M, Salari M, Wolke R, Labou VT, Imbalzano G, Camozzi S, MERELLO M, Bloem BR, Capato T, Djaldetti R, Doherty K, Fasano A, Tibar H, Lopiano L, Margraf NG, Moreau C, Ugawa Y, Bhidayasiri R, Tinazzi M; International Parkinson and Movement Disorders Society Task Force on Postural Abnormalities. Predictors and Pathophysiology of Axial Postural Abnormalities in Parkinsonism: A Scoping Review. Mov Disord Clin Pract. 2023 Sep 25;10(11):1585-1596. doi: 10.1002/mdc3.13879. PMID: 38026508; PMCID: PMC10654876. 227. Kailash P. Bhatia MD, DM, FRCP, Marcelo MERELLO MD, PhD. A Leaving Note from the Editors of Movement Disorders Clinical Practice Movement Disorders Clinical Practice Volume 11, Issue 12 p. 1477-1477 228. Wilken M, Andres DS, Bianchi G, Hallett M, MERELLO M. Persistence of Basal Ganglia Oscillatory Activity During Tremor Attenuation by Movement in Parkinson's Disease Patients. Mov Disord. 2024 May;39(5):768-777. doi: 10.1002/mds.29679. Epub 2024 Feb 28. PMID: 38415321. 229. Wilken M, Cruz I, Villamil F, Castillo-Torres SA, Alscher F, Andres DS, MERELLO M. Neurophysiological Analysis of the Posterior Subthalamic Area in a Patient with Holmes' Tremor. Mov Disord. 2024 Mar;39(3):623-625. doi: 10.1002/mds.29705. Epub 2024 Jan 17. PMID: 38230800.